CN1956993B - 具有抗炎活性的大环内酯 - Google Patents

具有抗炎活性的大环内酯 Download PDF

Info

Publication number
CN1956993B
CN1956993B CN2005800035758A CN200580003575A CN1956993B CN 1956993 B CN1956993 B CN 1956993B CN 2005800035758 A CN2005800035758 A CN 2005800035758A CN 200580003575 A CN200580003575 A CN 200580003575A CN 1956993 B CN1956993 B CN 1956993B
Authority
CN
China
Prior art keywords
alkyl
group
compound
heteroaryl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800035758A
Other languages
English (en)
Chinese (zh)
Other versions
CN1956993A (zh
Inventor
A·梅雷乌
M·纳普勒塔诺
F·奥纳吉
E·莫里吉
F·派拉茨尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Original Assignee
Zambon Group SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA filed Critical Zambon Group SpA
Publication of CN1956993A publication Critical patent/CN1956993A/zh
Application granted granted Critical
Publication of CN1956993B publication Critical patent/CN1956993B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN2005800035758A 2004-01-29 2005-01-25 具有抗炎活性的大环内酯 Expired - Fee Related CN1956993B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2004A000124 2004-01-29
IT000124A ITMI20040124A1 (it) 2004-01-29 2004-01-29 Macrolidi ad attivita' antiinfiammatoria
PCT/EP2005/050312 WO2005075494A1 (en) 2004-01-29 2005-01-25 Macrolides with antiinflammatory activity

Publications (2)

Publication Number Publication Date
CN1956993A CN1956993A (zh) 2007-05-02
CN1956993B true CN1956993B (zh) 2012-10-31

Family

ID=34835570

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800035758A Expired - Fee Related CN1956993B (zh) 2004-01-29 2005-01-25 具有抗炎活性的大环内酯

Country Status (10)

Country Link
US (1) US7507721B2 (https=)
EP (1) EP1713818A1 (https=)
JP (1) JP4709774B2 (https=)
CN (1) CN1956993B (https=)
AU (1) AU2005210032B9 (https=)
CA (1) CA2554070C (https=)
EA (1) EA010906B1 (https=)
IL (1) IL176846A (https=)
IT (1) ITMI20040124A1 (https=)
WO (1) WO2005075494A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
RU2455308C2 (ru) 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
EP2102226B1 (en) * 2006-12-12 2012-08-22 ZAMBON S.p.A. Macrolide compounds endowed with antiinflammatory activity
TWI830987B (zh) 2020-03-12 2024-02-01 美商碩騰服務公司 免疫調節脲氮雜內酯
MX2024002892A (es) * 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.
WO2024194494A1 (en) * 2023-03-22 2024-09-26 Epiendo Pharmaceuticals Ehf Azithromycin derivatives for use in the treatment of eosinophil-related diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306205B1 (it) 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof

Also Published As

Publication number Publication date
JP2007519685A (ja) 2007-07-19
AU2005210032B9 (en) 2011-06-09
WO2005075494A1 (en) 2005-08-18
CN1956993A (zh) 2007-05-02
IL176846A (en) 2011-01-31
EA200601368A1 (ru) 2007-02-27
AU2005210032A1 (en) 2005-08-18
ITMI20040124A1 (it) 2004-04-29
JP4709774B2 (ja) 2011-06-22
AU2005210032B2 (en) 2011-01-20
US20070167381A1 (en) 2007-07-19
CA2554070C (en) 2011-10-11
CA2554070A1 (en) 2005-08-18
IL176846A0 (en) 2006-10-31
EA010906B1 (ru) 2008-12-30
EP1713818A1 (en) 2006-10-25
US7507721B2 (en) 2009-03-24

Similar Documents

Publication Publication Date Title
RU2330856C2 (ru) Макролидные соединения, обладающие противовоспалительной активностью
JPH053476B2 (https=)
RU2320668C2 (ru) 9а-азалиды с противовоспалительной активностью
CN1956993B (zh) 具有抗炎活性的大环内酯
JP2008519787A (ja) マクロロン化合物
CN101558078B (zh) 具有抗炎活性的大环内酯化合物
EP1841776A2 (en) Decladinosyl-macrolides with anti-inflammatory activity
JPH0853355A (ja) Ｉｌ−５産生抑制剤
JPH08104638A (ja) Ｉｌ−５産生抑制剤
JP2007223900A (ja) ６−ｏ−置換ケトライド誘導体
JPWO1998042720A1 (ja) エリスロマイシンａ誘導体
CN101148462A (zh) 阿奇霉素衍生物及其应用
JPWO1999021867A1 (ja) エリスロマイシンａ誘導体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121031

Termination date: 20150125

EXPY Termination of patent right or utility model